Loading…
Ypsomed signed an agreement to establish its first manufacturing base in China at the Changzhou National Hi-Tech District, with a total investment of over €40 million, focusing on injection pens and needles, expected to start production in 2024.
“The program, with a total investment of over 40 million euros, will focus on the R&D, production and assembly of injection pens and needles.”changzhou.gov.cn
Summarized from public sources; check the original articles before acting on it.